Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3976495 | Brachytherapy | 2015 | 6 Pages |
Abstract
The TSO can be added with minimal planning time increase but with the potential of dramatic and systematic reductions in OAR D2ccs and in some cases with concurrent increase in target dose coverage. These single-fraction modifications would be magnified over the course of four to five intracavitary insertions and may have real clinical implications in terms of decreasing both acute and late toxicities.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Manju Sharma, Emma C. Fields, Dorin A. Todor,